Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK, Mounjaro is a prescription-only medicine and every legitimate supply comes with a clinical assessment. Private monthly costs vary by dose and provider, broadly ranging from around £149 to £375 or more since Eli Lilly raised its UK list price in September 2025 — so the honest answer to how much 'low cost Mounjaro' actually means is: it depends on what that cost includes. Before comparing numbers, it is worth understanding what a legitimate price must cover and what some headline figures quietly leave out. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed for weight management in adults, available only on prescription following clinical assessment by a qualified prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro's UK list price shifted substantially on 1 September 2025, when Eli Lilly increased it markedly, the highest-strength pen moved from roughly £122 to around £330 per four-week supply. Private providers set their own prices on top of that wholesale cost, so the range you see advertised reflects different margins, different levels of clinical service, and sometimes very different definitions of what 'included' means.
The full picture of Mounjaro pricing in the UK also shifts by dose. A 2.5mg starter pen sits at the lower end of that range; the 10mg and above are considerably more. That dose-by-dose difference matters because treatment usually begins at 2.5mg and is titrated upward by the prescriber as your body settles, so the first month's bill is not necessarily what you will pay in month four. You can read more about how costs change at each stage on the Mounjaro cost page.
NICE's appraisal of tirzepatide (TA1026, published December 2024) sets out the clinical criteria underpinning its recommendation for NHS use. Private eligibility follows the licensed indication in the SmPC, which covers adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition. A prescriber assesses the whole picture; BMI alone is never the only consideration.
A figure quoted per pen or per month might look straightforward. In practice, some providers charge separately for the consultation, the written prescription, and delivery. A few charge a monthly membership before you reach the medicine itself. Add those up and a 'low cost' listing can match or exceed a genuinely all-in price elsewhere.
It is also worth asking what clinical oversight is included after the first prescription. Dose increases, repeat supplies, questions about side effects, these need a prescriber's attention each time. If aftercare means an automated top-up with no review, that is a clinical gap as much as it is a cost consideration. The NHS information on tirzepatide describes the monitoring a patient should expect throughout treatment; checking whether your provider delivers that is a reasonable question to ask.
Specific dose costs, if that is what you are researching, are covered in more detail on the 5mg Mounjaro cost page and the 10mg Mounjaro cost page.
Cheapest is not a race we entered. One transparent price at nume covers the clinical consultation, the prescription, the medicine, and free next-working-day delivery. There is no consultation fee on top, no prescription surcharge, no delivery charge, no membership. If you order before 12pm on a working day and your prescriber approves it, the pen is dispatched the same day, arriving with DPD the next working morning, tracked to your door, in a plain box that gives nothing away.
Every repeat order is reviewed by a GPhC-registered Independent Prescriber before anything is dispensed. That is not a formality; it is why our pharmacy holds GPhC premises registration 9012878, verifiable on the GPhC register. You can read about the clinical team behind the service on the clinical team page. Our current treatment pricing is published on the treatment page, we do not list per-pen figures in article copy, because the right starting point is a consultation, not a price comparison.
The MHRA has warned publicly about fake weight-loss pens sold online, including counterfeit tirzepatide pens seized from an illicit UK manufacturing site in late 2025. Prices that look unusually low, sellers on social media, and offers made without any clinical assessment are the clearest red flags. A small saving is not the measure that keeps you safe, genuine supply through the licensed UK chain, with a prescriber-reviewed prescription, is.
If you come across a 'discount code' for Mounjaro from a seller you cannot verify, that is itself a warning sign. Mounjaro is a prescription-only medicine; legitimate providers do not run promotional codes tied to POM supply. We do not either. You can verify any online pharmacy on the GPhC register before sharing personal or payment details. Suspect sellers can be reported through the MHRA Yellow Card scheme. For a broader look at what affects the overall cost, including where to find low price Mounjaro from a clinically verified provider, the Mounjaro cost overview covers the landscape in full.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.